Skip to main content
. 2022 Jun 7;7(3):100511. doi: 10.1016/j.esmoop.2022.100511

Figure 1.

Figure 1

Overall survival according to KRASmutation status.

P value: P value from log-rank test. HR (FTD/TPI versus placebo) and 95% CI obtained from a distinct unstratified Cox model for each subgroup. P val. inter: P value from unstratified Cox model including arm treatment, subgroup and their interaction in the model. Ties handling method: Efron.

CI, confidence interval; FTD/TPI, trifluridine/tipiracil; HR, hazard ratio; OS, overall survival.